Inaktiver Wert

Vitae Pharmaceuticals Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae	17.10.16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	15.09.16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	15.09.16
NASDAQ Comp : Wall Street termine dans le rouge, Apple monte encore	14.09.16
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions	14.09.16

Manager	Titel	Alter	Seit
Ambrose Bailey PSD	President	60	25.10.16
Carole A. Sable CTO	Chief Tech/Sci/R&D Officer	62	06.06.16
John Grosso BRD	Director/Board Member	-	-

Aufsichtsräte	Titel	Alter	Seit
John Grosso BRD	Director/Board Member	-	-

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	-3,75 %	86,13 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+1,97 %	39,82 Mrd.
UCB	+56,59 %	25,23 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-14,82 %	15,36 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-8,82 %	11,95 Mrd.
INCYTE CORPORATION	-16,29 %	11,6 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41,58 %	11,51 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+6,14 %	8,71 Mrd.
INNOVENT BIOLOGICS, INC.	-7,02 %	8,12 Mrd.